The pharmaceutical community is excited by retatrutide, a new dual GIP and GLP-1 target that’s showing remarkable results in preliminary studies . This treatment works by replicating natural hormones to affect appetite and promote feelings of satisfaction , ultimately contributing to noticeable fat reduction . While still under investigation and… Read More